Literature DB >> 30340140

Design, synthesis, and X-ray studies of potent HIV-1 protease inhibitors incorporating aminothiochromane and aminotetrahydronaphthalene carboxamide derivatives as the P2 ligands.

Arun K Ghosh1, Ravindra D Jadhav2, Hannah Simpson2, Satish Kovela2, Heather Osswald2, Johnson Agniswamy3, Yuan-Fang Wang3, Shin-Ichiro Hattori4, Irene T Weber3, Hiroaki Mitsuya5.   

Abstract

We describe the design, synthesis, and biological evaluation of a series of novel HIV-1 protease inhibitors with carboxamide derivatives as the P2 ligands. We have specifically designed aminothiochromane and aminotetrahydronaphthalene-based carboxamide ligands to promote hydrogen bonding and van der Waals interactions in the active site of HIV-1 protease. Inhibitors 4e and 4j have shown potent enzyme inhibitory and antiviral activity. High resolution X-ray crystal structures of 4d- and 4k-bound HIV-1 protease revealed molecular insights into the ligand-binding site interactions.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Design and synthesis; Drug resistance; HIV-1 protease inhibitors; P2 ligand; X-ray crystal structure

Mesh:

Substances:

Year:  2018        PMID: 30340140      PMCID: PMC6237192          DOI: 10.1016/j.ejmech.2018.09.046

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  51 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

3.  Synthesis and biological evaluation of novel amprenavir-based P1-substituted bi-aryl derivatives as ultra-potent HIV-1 protease inhibitors.

Authors:  Jianwei Yan; Ning Huang; Shukun Li; Liu-Meng Yang; Weiqiang Xing; Yong-Tang Zheng; Youhong Hu
Journal:  Bioorg Med Chem Lett       Date:  2012-01-21       Impact factor: 2.823

4.  Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding Group.

Authors:  Christopher J Bungard; Peter D Williams; Jeanine E Ballard; David J Bennett; Christian Beaulieu; Carolyn Bahnck-Teets; Steve S Carroll; Ronald K Chang; David C Dubost; John F Fay; Tracy L Diamond; Thomas J Greshock; Li Hao; M Katharine Holloway; Peter J Felock; Jennifer J Gesell; Hua-Poo Su; Jesse J Manikowski; Daniel J McKay; Mike Miller; Xu Min; Carmela Molinaro; Oscar M Moradei; Philippe G Nantermet; Christian Nadeau; Rosa I Sanchez; Tummanapalli Satyanarayana; William D Shipe; Sanjay K Singh; Vouy Linh Truong; Sivalenka Vijayasaradhi; Catherine M Wiscount; Joseph P Vacca; Sheldon N Crane; John A McCauley
Journal:  ACS Med Chem Lett       Date:  2016-05-09       Impact factor: 4.345

5.  Variations of the P2 group in HIV-1 protease inhibitors containing a tertiary alcohol in the transition-state mimicking scaffold.

Authors:  Jenny K Ekegren; Johan Gising; Hans Wallberg; Mats Larhed; Bertil Samuelsson; Anders Hallberg
Journal:  Org Biomol Chem       Date:  2006-07-06       Impact factor: 3.876

6.  Asymmetric Catalysis by Architectural and Functional Molecular Engineering: Practical Chemo- and Stereoselective Hydrogenation of Ketones.

Authors:  Ryoji Noyori; Takeshi Ohkuma
Journal:  Angew Chem Int Ed Engl       Date:  2001-01-05       Impact factor: 15.336

7.  Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors.

Authors:  Arun K Ghosh; Lisa M Swanson; Hanna Cho; Sofiya Leshchenko; Khaja Azhar Hussain; Stephanie Kay; D Eric Walters; Yasuhiro Koh; Hiroaki Mitsuya
Journal:  J Med Chem       Date:  2005-05-19       Impact factor: 7.446

8.  TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolates.

Authors:  Sandra De Meyer; Hilde Azijn; Dominique Surleraux; Dirk Jochmans; Abdellah Tahri; Rudi Pauwels; Piet Wigerinck; Marie-Pierre de Béthune
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

9.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

10.  Palladium-catalyzed carbonylation reactions of aryl bromides at atmospheric pressure: a general system based on Xantphos.

Authors:  Joseph R Martinelli; Donald A Watson; Dominique M M Freckmann; Timothy E Barder; Stephen L Buchwald
Journal:  J Org Chem       Date:  2008-08-23       Impact factor: 4.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.